BYLLATRIN

Serial Number 87332064
606

Registration Progress

Application Filed
Feb 10, 2017
Under Examination
Jul 18, 2017
Approved for Publication
May 23, 2017
Published for Opposition
May 23, 2017
Registered

Trademark Image

BYLLATRIN

Basic Information

Serial Number
87332064
Filing Date
February 10, 2017
Published for Opposition
May 23, 2017
Abandonment Date
August 20, 2018
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 20, 2018
Classes
005

Rights Holder

UPSHER-SMITH LABORATORIES, LLC

16
Address
6701 EVENSTAD DRIVE
MAPLE GROVE, MN 55369

Ownership History

Upsher-Smith Laboratories

Original Applicant
03
Maple Grove, MN

Upsher-Smith Laboratories

Owner at Publication
03
Maple Grove, MN

UPSHER-SMITH LABORATORIES, LLC

New Owner After Publication #1
16
MAPLE GROVE, MN

Legal Representation

Attorney
Frances M. Jagla

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

15 events
Date Code Type Description Documents
Aug 20, 2018 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 20, 2018 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Dec 14, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 12, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 12, 2017 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 12, 2017 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 23, 2017 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jul 18, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 23, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 23, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 3, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 13, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 12, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 16, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 14, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of central nervous system disorders
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005